Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic ImplicationsAnna N. Ligezka, Éva Morava, Kishore Garapati et al.|Annals of Neurology|2021Cited by 57
COQ2 nephropathy: a treatable cause of nephrotic syndrome in childrenMichelle C. Starr, Christina Lam, Irene J. Chang et al.|Pediatric Nephrology|2018Cited by 43
Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history studyPeter Witters, Éva Morava, Andrew C. Edmondson et al.|Orphanet Journal of Rare Diseases|2021Cited by 21
Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylationDiederik De Graef, Éva Morava, Anna N. Ligezka et al.|Molecular Genetics and Metabolism|2023Cited by 16
Coagulation Abnormalities in a Prospective Cohort of 50 Patients with PMM2-Congenital Disorder of GlycosylationDiederik De Graef, Éva Morava, Anna N. Ligezka et al.|SSRN Electronic Journal|2023Cited by 0